Bladder drug delivery via catheter instillation is a widely used treatment for recurrence of superficial bladder cancer. Intravesical instillation of liposomal botulinum toxin has recently shown promise in the treatment of overactive bladder and interstitial cystitis/bladder pain syndrome, and studies of liposomal tacrolimus instillations show promise in the treatment of hemorrhagic cystitis. Liposomes are lipid vesicles composed of phospholipid bilayers surrounding an aqueous core that can encapsulate hydrophilic and hydrophobic drug molecules to be delivered to cells via endocytosis. This review will present new developments on instillations of liposomes and liposome-encapsulated drugs into the urinary bladder for treating lower urinary tract dysfunction.
Joseph J. Janicki, Michael B. Chancellor,* Jonathan Kaufman, Michele A. Gruber, and David D. Chancellor
Download Paper
SPOTLIGHT: High Throughput IGRT on SAARP – A Biotech Perspective
https://vimeo.com/1099450901?share=copy#t=0 In this insightful session, Derrik Germain dives deep into the world of high-throughput image-guided radiotherapy (IGRT) using the SARRP system. He shares his expertise on optimizing workflows, improving throughput, and...